PATENT CLAIM ANALYSIS

Application Number: 16023232
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["549", "397000"]

Abstract:
Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical compositions and the uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.

Claim (Index 7):
The composition of  claim 6  wherein said compound or said therapeutically acceptable salt thereof is present in a therapeutically effective amount.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 1.25806
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15434508', '15093178', '14714484', '14917792', '14779191']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7955519131141808
- 35 USC 102 Novelty (BERT): 0.6153549236366161
- Combined Prediction Score: 0.7775322141664244
- Mean Citation Score: 444.961634
- Max Citation Score: 550.91327
- Similarity Product: 524.6241073457837

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test